Gene: PNPLA8
Official Full Name: patatin like domain 8, phospholipase A2provided by HGNC
Gene Summary: This gene encodes a member of the patatin-like phospholipase domain containing protein family. Members of this family are phospholipases which catalyze the cleavage of fatty acids from membrane phospholipids. The product of this gene is a calcium-independent phospholipase. Mutations in this gene have been associated with mitochondrial myopathy with lactic acidosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23352 | PNPLA8 Knockout cell line (HeLa) | Human | PNPLA8 | 1:3~1:6 | Negative | Online Inquiry |
KO23353 | PNPLA8 Knockout cell line (HCT 116) | Human | PNPLA8 | 1:2~1:4 | Negative | Online Inquiry |
KO23354 | PNPLA8 Knockout cell line (HEK293) | Human | PNPLA8 | 1:3~1:6 | Negative | Online Inquiry |
KO23355 | PNPLA8 Knockout cell line (A549) | Human | PNPLA8 | 1:3~1:4 | Negative | Online Inquiry |
PNPLA8 Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically modified to disrupt the PNPLA8 gene, which encodes a protein involved in lipid metabolism. These knockout lines serve as crucial tools for researchers seeking to understand the functional implications of PNPLA8 deficiency on cellular processes such as triglyceride storage and energy homeostasis. By creating a loss-of-function model, these cell lines facilitate investigations into the gene's role in metabolic disorders and related pathologies.
The primary function of PNPLA8 is to modulate the enzymatic activity that influences lipid droplet dynamics and fatty acid mobilization. In the absence of functional PNPLA8, studies have demonstrated altered lipid accumulation, highlighting the gene’s significance in maintaining cellular lipid balance and contributing to overall metabolic health. By utilizing these knockout cell lines, researchers can observe the downstream effects of PNPLA8 loss, thereby elucidating its involvement in conditions such as obesity, diabetes, and non-alcoholic fatty liver disease.
From a scientific perspective, the PNPLA8 Gene Knockout Cell Lines offer invaluable applications in both basic and applied research settings. They enable the exploration of lipid metabolic pathways, the testing of potential therapeutic agents, and the development of targeted interventions for metabolic diseases. Moreover, these cell lines can serve as screening tools for evaluating the effects of compounds on lipid metabolism, making them a versatile asset in pharmaceutical research.
Compared to traditional knockout models, our PNPLA8 Gene Knockout Cell Lines are characterized by their ease of use, consistent performance, and reproducibility, providing researchers with reliable data in a shorter timeframe. Their specificity allows for a direct examination of PNPLA8-related pathways without the confounding effects of other genetic variations.
In conclusion, the PNPLA8 Gene Knockout Cell Lines represent an essential resource for researchers and clinicians dedicated to advancing our understanding of lipid metabolism and related disorders. Our company prides itself on delivering high-quality, rigorously validated biological products, ensuring our users have access to the most reliable tools for their groundbreaking work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.